Steven T. Reed, O.D., President of the American Optometric Association, discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults over 50, and the importance of early diagnosis and preventive care.
Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.
Gábor Balázsi, Ph.D. from the Louis and Beatrice Laufer Center for Physical and Quantitative Biology and the Department of Biomedical Engineering at Stony Brook University in the U.S., shares his perspective on the field of synthetic biology in terms of the past, present and future.
Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group Genomic medicine approaches – two contrasting case studies to note including the overall perspective, as well as the challenges and concerns in the field.
The European Red Cell Society’s met the partners of the EU intellectual training network RELEVANCE at Mount of Truth in Ascona, Switzerland to discuss the latest progress.
The healthcare sector is constantly changing, and many practices have been modified to become more efficient: So how can technology help with advancing surgeries?
Here, Jaqueline Zhao and Tim Jackson discuss the new regulations coming into force for China in 2019, after the gene-editing scandal which created international headlines.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.
Takashi Nakazawa, Professor at Nara Women’s University explores some fascinating aspects of chemistry and the archaeology of collagen, as well as a view point expressed on analysing ancient specimens in a collaborative way.
Swansea University Medical School’s Master’s degree in genomic medicine has been designed to help NHS staff to understand and use the growing personalised medicine approach.
Laura Hagerty, PhD, Scientific Portfolio Director at the Muscular Dystrophy Association, highlights strategies for gene correction to treat Duchenne muscular dystrophy.
